Skip to main content

Vision Disorders

0
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Bausch + Lomb
Bausch + LombNJ - Bridgewater
2 programs
Investigational Cleaning & Disinfecting SolutionN/A
PureVision Multi-Focal contact lensesN/A
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
2 programs
Investigational Cleaning & Disinfecting SolutionN/A1 trial
PureVision Multi-Focal contact lensesN/A1 trial
Active Trials
NCT01318577Completed444Est. Jun 2011
NCT00985231Completed272Est. Dec 2009
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
JJVC Marketed Contact LensN/A1 trial
Active Trials
NCT02595502Completed286Est. Nov 2015
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Precision tinted lensesN/A1 trial
Active Trials
NCT02680223CompletedEst. Dec 2019
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Welch-Allyn Spot Vision ScreenerN/A1 trial
Active Trials
NCT03479021Unknown100Est. May 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado TherapeuticsWelch-Allyn Spot Vision Screener
City TherapeuticsPrecision tinted lenses
Johnson & JohnsonJJVC Marketed Contact Lens
Bausch HealthInvestigational Cleaning & Disinfecting Solution
Bausch HealthPureVision Multi-Focal contact lenses

Clinical Trials (5)

Total enrollment: 1,102 patients across 5 trials

NCT03479021Colorado TherapeuticsWelch-Allyn Spot Vision Screener

SPOT Vision Screening

Start: May 2017Est. completion: May 2019100 patients
N/AUnknown
NCT02680223City TherapeuticsPrecision tinted lenses

Efficacy of Coloured Overlays and Lenses for Reading Difficulty

Start: Jan 2016Est. completion: Dec 2019
N/ACompleted
NCT02595502Johnson & JohnsonJJVC Marketed Contact Lens

Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses

Start: Sep 2015Est. completion: Nov 2015286 patients
N/ACompleted
NCT01318577Bausch HealthInvestigational Cleaning & Disinfecting Solution

Study of A New Contact Lens Cleaning and Disinfecting Solution

Start: Nov 2010Est. completion: Jun 2011444 patients
N/ACompleted
NCT00985231Bausch HealthPureVision Multi-Focal contact lenses

Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers

Start: Sep 2009Est. completion: Dec 2009272 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.